Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000975341 | SCV001123224 | likely benign | Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2024-09-17 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002511005 | SCV002821081 | likely benign | not provided | 2022-10-01 | criteria provided, single submitter | clinical testing | RTEL1: BP4, BP7 |
Gene |
RCV002511005 | SCV005392418 | uncertain significance | not provided | 2024-04-30 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis indicates that this variant does not alter splicing; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV004958340 | SCV005487378 | likely benign | Inborn genetic diseases | 2024-12-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001832221 | SCV002095532 | likely benign | Dyskeratosis congenita | 2021-05-10 | no assertion criteria provided | clinical testing |